Literature DB >> 9488898

Reducing asthma morbidity in the community: the effect of a targeted nurse-run asthma clinic in an English general practice.

J Dickinson1, S Hutton, A Atkin, K Jones.   

Abstract

Although most primary health care teams in the U.K. now offer proactive care for patients with asthma, there is relatively little published evidence showing the effectiveness of such innovations. This may be due in part to lack of targeting of extra care towards those most in need. Therefore, to demonstrate the benefits of targeted nurse-run asthma clinic care in a seven-partner general practice in a mixed urban and rural area of North Lincolnshire in the east of England, a cohort of 173 patients, with asthma selected predominantly by having high morbidity in a postal survey, completed 12 months follow-up in a nurse-run asthma clinic. A longitudinal comparison was conducted in terms of: changes in morbidity index category, inhaler technique score, knowledge score, use of inhaled steroids, use of salmeterol, method of administration of beta(2)-agonist medication and frequent use of peak flow meters. The number with high morbidity fell from 123 (71.1%) at the initial consultation to 14 (8.1%) at the 12-month review. Those with full marks on inhaler technique rose from 28 (16.2%) to 142 (82.1%), and with full marks on asthma knowledge rose from 7 (4.0%) to 98 (56.6%). The numbers of patients using inhaled steroids and salmeterol rose from 127 (73.4%) to 171 (98.9%) and from 5 (2.9%) to 35 (20.2%), respectively. The preferred inhaler device for beta(2)-bronchodilator medication changed from metered dose aerosol to dry powder. Regular use of peak flow meters in 157 subjects aged 5 years and over rose from 43 (27.4%) to 116 (73.9%). These data clearly demonstrate the benefits of targeted proactive nurse-run asthma care in terms of reduced morbidity for patients. The authors recommend the morbidity index targeting concept to other primary health care teams.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9488898     DOI: 10.1016/s0954-6111(97)90011-1

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  9 in total

Review 1.  Issues at the interface between primary and secondary care in the management of common respiratory disease. 3: Providing better asthma care: what is there left to do?

Authors:  R G Neville; B G Higgins
Journal:  Thorax       Date:  1999-09       Impact factor: 9.139

2.  Predictive value of a simple asthma morbidity index in a general practice population.

Authors:  K Jones; R Cleary; M Hyland
Journal:  Br J Gen Pract       Date:  1999-01       Impact factor: 5.386

3.  Targeted routine asthma care in general practice using telephone triage.

Authors:  Kevin Gruffydd-Jones; Sandra Hollinghurst; Sabbi Ward; Gordon Taylor
Journal:  Br J Gen Pract       Date:  2005-12       Impact factor: 5.386

4.  [Not Available].

Authors:  G Rao
Journal:  West J Med       Date:  2000-08

5.  Inhaler technique in Turkish people with poor English: a case of information discrimination?

Authors:  Larry Goodyer; Imogen Savage; Zeynep Dikmen
Journal:  Pharm World Sci       Date:  2006-07-04

6.  Organising primary health care for people with asthma: the patient's perspective.

Authors:  C Paterson; N Britten
Journal:  Br J Gen Pract       Date:  2000-04       Impact factor: 5.386

Review 7.  Systematic review of studies of quality of clinical care in general practice in the UK, Australia and New Zealand.

Authors:  M E Seddon; M N Marshall; S M Campbell; M O Roland
Journal:  Qual Health Care       Date:  2001-09

Review 8.  Objectives, methods and content of patient education programmes for adults with asthma: systematic review of studies published between 1979 and 1998.

Authors:  P Sudre; S Jacquemet; C Uldry; T V Perneger
Journal:  Thorax       Date:  1999-08       Impact factor: 9.139

Review 9.  Primary care based clinics for asthma.

Authors:  Elora Baishnab; Charlotta Karner
Journal:  Cochrane Database Syst Rev       Date:  2012-04-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.